RIBOCICLIB PLUS EVEROLIMUS PHASE 0/2 CLINICAL TRIAL FOR RECURRENT GLIOBLASTOMAS.

PIs: Nader Sanai, M.D., FAANS, FACS
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological InstituteZ
NeuroTrials, LLC

Close Menu